<DOC>
	<DOCNO>NCT00402935</DOCNO>
	<brief_summary>RATIONALE : Comparing result diagnostic procedure , ultrasound , do , , chemotherapy may help doctor learn side effect chemotherapy help plan best treatment . PURPOSE : This clinical trial study ovarian damage young premenopausal woman undergo chemotherapy cancer .</brief_summary>
	<brief_title>Ovarian Damage Young Premenopausal Women Undergoing Chemotherapy Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine incidence time ovarian dysfunction/damage young premenopausal woman undergo cytotoxic chemotherapy cancer . - Determine feasibility prospective , randomize study ass gonadotropin analogue protect ovary cytotoxic effect chemotherapy . - Determine number patient require adequate power test hypothesis . OUTLINE : This pilot , prospective study . Patients undergo transvaginal transabdominal ultrasound measure ovarian volume count number antral follicle baseline , 3 month begin cytotoxic chemotherapy , 6 month completion treatment . Patients undergo blood collection time point follicle-stimulating hormone , estradiol , inhibin B level . Patients also ask fill questionnaire estrogen-depletion symptom time . Patients also keep calendar menstrual bleeding hormonal medication . PROJECTED ACCRUAL : A total 22 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Infertility</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis cancer , include , limited , follow : Acute lymphocytic leukemia Acute myeloid leukemia Hodgkin 's lymphoma Must primary disease significant chance longterm survival therapy Scheduled receive chemotherapeutic agent know associated ovarian failure , include follow : Cyclophosphamide Mechlorethamine hydrochloride Busulfan Procarbazine hydrochloride Chlorambucil Melphalan Ifosfamide Cisplatin Carboplatin Postmenarchal premenopausal PATIENT CHARACTERISTICS : Female Weight â‰¤ 250 pound Not pregnant PRIOR CONCURRENT THERAPY : No prior concurrent totalbody irradiation radiotherapy pelvis Concurrent bone marrow transplantation allow Concurrent oral contraception and/or gonadotropin releasinghormone analogue allow</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>long-term effect secondary cancer therapy adult</keyword>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>sexual dysfunction infertility</keyword>
	<keyword>sexuality reproductive issue</keyword>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated adult acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia myeloid malignancy</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage III childhood Hodgkin lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
	<keyword>stage IV childhood Hodgkin lymphoma</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
</DOC>